APA (7th ed.) Citation

T, A., M, K., M, O., M, Y., H, O., S, S., . . . H, K. (2026). Preclinical efficacy of combination therapy with allogeneic induced pluripotent stem cell-derived invariant natural killer T and α-galactosylceramide-pulsed antigen-presenting cells. Stem cell research & therapy, 17(1), . https://doi.org/10.1186/s13287-026-04994-7

Chicago Style (17th ed.) Citation

T, Aoki, et al. "Preclinical Efficacy of Combination Therapy with Allogeneic Induced Pluripotent Stem Cell-derived Invariant Natural Killer T and α-galactosylceramide-pulsed Antigen-presenting Cells." Stem Cell Research & Therapy 17, no. 1 (2026). https://doi.org/10.1186/s13287-026-04994-7.

MLA (9th ed.) Citation

T, Aoki, et al. "Preclinical Efficacy of Combination Therapy with Allogeneic Induced Pluripotent Stem Cell-derived Invariant Natural Killer T and α-galactosylceramide-pulsed Antigen-presenting Cells." Stem Cell Research & Therapy, vol. 17, no. 1, 2026, https://doi.org/10.1186/s13287-026-04994-7.